In this Section |
273170 A State Partnership in an Initiative to Eliminate Non-medically Indicated (Elective) DeliveriesMonday, October 29, 2012
: 9:10 AM - 9:30 AM
Elective early term labor induction and cesarean section are common and increasing in the United States. The California Department of Public Health (CDPH) Maternal, Child and Adolescent Health (MCAH) Division allocated Title V block grant funds to the California Maternal Quality Care Collaborative to develop a toolkit on the “Elimination of Non-medically Indicated (Elective) Deliveries Before 39 Weeks Gestational Age.” In a first ever licensing agreement for MCAH, CDPH added March of Dimes to the partnership for further development of the toolkit as well as national and state dissemination. Simultaneously, CDPH-MCAH funded a local health department to lead county-wide adoption of strategies to reduce early term elective deliveries which not only led to reductions in elective deliveries but yielded a leadership implementation guide for other local health departments. The challenges, achievements and lessons learned from this project and the on-going partnership will be shared and discussed.
Learning Areas:
Administration, management, leadershipClinical medicine applied in public health Program planning Learning Objectives: Keywords: Maternal and Child Health, Birth Outcomes
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: Is a Public Health Medical Officer in Maternal, Child, and Adolescent Health in the Center for Family Health of the California Department of Public Health. She is board certified in Emergency Medicine and transitioned to public health after 20 years in academic medicine focusing on family violence. She teaches medical and MPH students at University of California, Davis. She earned her medical degree from Michigan State University and her Masters in Public Health from UCLA. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 3050.0: Partnerships in Reducing Early Elective Deliveries
|